These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 24953075)

  • 1. The role of screening tools in diagnosing neuropathic pain.
    Mulvey MR; Bennett MI; Liwowsky I; Freynhagen R
    Pain Manag; 2014 May; 4(3):233-43. PubMed ID: 24953075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Dutch version of the DN4 diagnostic questionnaire for neuropathic pain.
    van Seventer R; Vos C; Giezeman M; Meerding WJ; Arnould B; Regnault A; van Eerd M; Martin C; Huygen F
    Pain Pract; 2013 Jun; 13(5):390-8. PubMed ID: 23113981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropathic pain.
    Kerstman E; Ahn S; Battu S; Tariq S; Grabois M
    Handb Clin Neurol; 2013; 110():175-87. PubMed ID: 23312640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathic pain: Definition, assessment and epidemiology.
    Bouhassira D
    Rev Neurol (Paris); 2019; 175(1-2):16-25. PubMed ID: 30385075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of pain and relative diagnostic performance of screening tools for neuropathic pain in cancer patients: A cross-sectional study.
    Pérez C; Sánchez-Martínez N; Ballesteros A; Blanco T; Collazo A; González F; Villoria J
    Eur J Pain; 2015 Jul; 19(6):752-61. PubMed ID: 25265909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of chronic neuropathic pain and the use of pain tools.
    White S
    Br J Nurs; 2004 Apr 8-21; 13(7):372-8. PubMed ID: 15150475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of neuropathic pain in children with cancer.
    Friedrichsdorf SJ; Nugent AP
    Curr Opin Support Palliat Care; 2013 Jun; 7(2):131-8. PubMed ID: 23635878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotyping neuropathic pain patients: implications for individual therapy and clinical trials.
    Reimer M; Helfert SM; Baron R
    Curr Opin Support Palliat Care; 2014 Jun; 8(2):124-9. PubMed ID: 24670811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathic pain in people with cancer (part 2): pharmacological and non-pharmacological management.
    Taverner T
    Int J Palliat Nurs; 2015 Aug; 21(8):380-4. PubMed ID: 26312533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropathic pain in children with cancer.
    Jacob E
    J Pediatr Oncol Nurs; 2004; 21(6):350-7. PubMed ID: 15475472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropathic pain in cancer: systematic review, performance of screening tools and analysis of symptom profiles.
    Mulvey MR; Boland EG; Bouhassira D; Freynhagen R; Hardy J; Hjermstad MJ; Mercadante S; Pérez C; Bennett MI
    Br J Anaesth; 2017 Oct; 119(4):765-774. PubMed ID: 29121284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening tools for neuropathic pain: are they adaptable in different languages and cultures?
    Attal N
    Pain Med; 2010 Jul; 11(7):985-6. PubMed ID: 20642726
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment.
    Baron R; Binder A; Wasner G
    Lancet Neurol; 2010 Aug; 9(8):807-19. PubMed ID: 20650402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and chronic neuropathic pain in the hospital setting: use of screening tools.
    Sadler A; Wilson J; Colvin L
    Clin J Pain; 2013 Jun; 29(6):507-11. PubMed ID: 23247003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropathic cancer pain: prevalence, severity, analgesics and impact from the European Palliative Care Research Collaborative-Computerised Symptom Assessment study.
    Rayment C; Hjermstad MJ; Aass N; Kaasa S; Caraceni A; Strasser F; Heitzer E; Fainsinger R; Bennett MI;
    Palliat Med; 2013 Sep; 27(8):714-21. PubMed ID: 23175513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and assessment of neuropathic pain through questionnaires.
    Attal N; Bouhassira D; Baron R
    Lancet Neurol; 2018 May; 17(5):456-466. PubMed ID: 29598922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agreement and correlation between the self-report leeds assessment of neuropathic symptoms and signs and Douleur Neuropathique 4 Questions neuropathic pain screening tools in subjects with low back-related leg pain.
    Walsh J; Rabey MI; Hall TM
    J Manipulative Physiol Ther; 2012; 35(3):196-202. PubMed ID: 22397741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosing neuropathic pain in patients with cancer: comparative analysis of recommendations in national guidelines from European countries.
    Piano V; Verhagen S; Schalkwijk A; Burgers J; Kress H; Treede RD; Hekster Y; Lanteri-Minet M; Engels Y; Vissers K
    Pain Pract; 2013 Jul; 13(6):433-9. PubMed ID: 23279302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis of neuropathic pain].
    Freynhagen R; Wirz S; Rolke R
    Ther Umsch; 2011 Sep; 68(9):495-500. PubMed ID: 21882145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosing postoperative neuropathic pain: a Delphi survey.
    Searle RD; Howell SJ; Bennett MI
    Br J Anaesth; 2012 Aug; 109(2):240-4. PubMed ID: 22649184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.